Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-22

Clinical Trial Update: Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease

View source ↗

Summary

A clinical trial is evaluating topical nifedipine 0.3% with lidocaine 1.5% for uncomplicated hemorrhoidal disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical nifedipine 0.3% plus lidocaine 1.5%

Snippet

Sponsor: Cardarelli Hospital | Conditions: Hemorrhoid Bleeding, Hemorrhoids Prolapse | Status: RECRUITING